Reviva Pharmaceuticals I... (RVPH)
1.80
0.22 (13.92%)
At close: Jan 15, 2025, 3:50 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -39.26M | -24.34M | -8.52M | -3.78M | -846.83K | -1.68M |
| Depreciation & Amortization | n/a | n/a | n/a | 591.00 | 645.00 | 17.72K |
| Stock-Based Compensation | 3.41M | 176.74K | 106.71K | n/a | n/a | 21.05K |
| Other Working Capital | 6.96M | 2.00M | -203.71K | -3.10M | 475.98K | 541.98K |
| Other Non-Cash Items | 239.22K | 194.71K | -1.55M | 2.39M | -6.41K | 28.24K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | 7.28M | 5.01M | -702.17K | -2.33M | 634.15K | 541.98K |
| Operating Cash Flow | -28.32M | -18.96M | -10.67M | -3.73M | -218.44K | -1.07M |
| Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 5.68M | 18.97K | 98.48K | 12.83M | n/a | 175.00K |
| Financial Cash Flow | 33.17M | 7.79M | 31.60M | 12.83M | 100.00K | 175.00K |
| Net Cash Flow | 4.85M | -11.17M | 20.93M | 8.76M | -118.44K | 118.64K |
| Free Cash Flow | -28.32M | -18.96M | -10.67M | -3.73M | -218.44K | -1.07M |